Recent Quotes
View Full List
My Watchlist
Medipharm Labs Corp
Merck Kgaa
Strive 1000 Growth ETF
Utz Brands Inc Class A Common Stock
lululemon athletica inc. - Common Stock
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(CSE:
VLAB
)
1.500
-0.120 (-7.41%)
Delayed Quote
Updated: 2:11 PM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about VLAB
Vesalius Longevity Labs Appoints Longevity Entrepreneur Dr. Peter Diamandis to Its Board of Directors
November 19, 2026
(November 19, 2026) - Vesalius Longevity Labs Inc. (CSE:VLAB) ("Vesalius" or the "Company"), a leading global peptide and longevity company, is pleased to announce the
Via
PressReach
Beyond GLP-1: The Next Wave of Peptide Innovation Could Unlock Billions in Biotech Growth
November 19, 2026
GLP-1 Treatments, Anticancer Research, and Emerging Therapeutic Technologies Are Driving the Next Chapter of Pharmaceutical Innovation
From
FN Media
Via
GlobeNewswire
Beyond GLP-1: The Next Wave of Peptide Innovation Could Unlock Billions in Biotech Growth
November 19, 2026
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:LLY),(NYSE:HIMS),(TSXV:PAIN),(CSE:VLAB) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Intellectual Property
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.